IL6 and infection: Since soluble IL-6R (sIL-6Rα) could enhance rather than inhibit the biological activity of IL-6 both in vitro and in vivo, the elevated levels of sIL-6Rα detected in the first weeks of infection in BF patients might result in increased IL-6 activity.